Company news

BeOne Medicines Ltd. news in 2024

BeOne Medicines Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Announcement on Voluntary Disclosure of the Change of the Company's NASDAQ Stock Code

December 23, 2024

Announcement on Voluntary Disclosure of the Incorporation of Commercial Products for Multiple Indications into the New Catalogue of Drugs for Basic National Medical Insurance

November 28, 2024

Announcement on Proposed Change of Company's English Name

November 14, 2024

Announcement on Using Partial Extra Raised Funds to Supplement Current Capital Permanently

November 12, 2024

Announcement on Convening the Q3 2024 Performance Briefing

November 5, 2024

Announcement on the Death of the Independent Non-executive Director

October 28, 2024

Announcement on the Appointment of Independent Non-executive Directors and Members of Audit Committee of the Board of Directors

September 26, 2024

Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024

September 20, 2024

Semi-annual Report in 2024

August 29, 2024

Announcement on Convening Semi-annual Performance Briefing 2024

August 21, 2024

Announcement on Key Financial Data for the First Half Year of 2024

August 7, 2024

Announcement on Change of Senior Executive

July 18, 2024

Announcement on Key Financial Data of 1st Quarter of 2024

May 8, 2024

Notice on Convening 2024 Annual General Meeting

April 28, 2024

2023 Annual Report

April 26, 2024

Announcement on Voluntary Disclosure of European Commission's Approval of Baize'an (Tislelizumab Injection) for First-line and Second-line Treatment of Three Non-small Cell Lung Cancer Indications

April 23, 2024

Announcement on Convening 2023 Annual Performance Meeting

April 19, 2024

Announcement on Equity Registration Date of 2024 Annual General Meeting

March 28, 2024

Announcement on Appointing Member of Advisory Committee on Commercial and Medical Affairs of Board of Directors

March 21, 2024

Announcement on Progress in Joint Investment with Related Party and Related Transaction

March 5, 2024

Announcement on 2023 Annual Preliminary Earnings Estimate

February 26, 2024

Announcement on Signing Consulting Agreement and Related Transaction

January 23, 2024

Decks in 2024